Stryker Corporation (LON:0R2S)
London · Delayed Price · Currency is GBP · Price in USD 357.81
-14.19 (-3.81%)
At close: Oct 31, 2025
Stryker Market Cap
Stryker has a market cap or net worth of 103.69 billion as of October 31, 2025. Its market cap has decreased by -2.08% in one year.
Market Cap
103.69B
Enterprise Value
114.19B
Revenue
18.14B
Ranking
n/a
PE Ratio
47.36
Stock Price
357.81
Market Cap Chart
Since June 21, 1983, Stryker's market cap has increased from 126.05M to 103.69B, an increase of 82,166.56%. That is a compound annual growth rate of 17.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 103.69B | -5.42% |
| Dec 31, 2024 | 109.64B | 22.74% |
| Dec 29, 2023 | 89.32B | 16.32% |
| Dec 30, 2022 | 76.79B | 3.07% |
| Dec 31, 2021 | 74.50B | 10.46% |
| Dec 31, 2020 | 67.45B | 13.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.37B |
| GSK plc | 71.57B |
| Haleon | 31.54B |
| Smith & Nephew | 11.91B |
| ConvaTec Group | 4.85B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.65B |